Requires licenses for US companies to export synthetic DNA and RNA to certain foreign entities.
This bill would make it harder for certain foreign entities to get advanced synthetic biology information from the U.S. It would require U.S. companies and researchers to get a special license before sending digital sequences of synthetic DNA or RNA to these entities. This aims to protect sensitive U.S. intellectual property and national security.
Today, there is no specific license required under current law for exporting digital sequences of synthetic DNA or RNA to "foreign entities of concern." If this bill becomes law, the United States Secretary of Commerce would be required to set up a new license system within one year. This would mean U.S. entities would need a license to export, re-export, or transfer these specific synthetic biology sequences to "foreign entities of concern." There would be some exceptions.
S 3452 · 119th Congress · December 11, 2025 · AI Summary by gemini-2.5-flash · 10/10
Sign in to see your representatives' phone numbers
7 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.